ICMRA Summit and Plenary 2021: high-level meeting on global health emergencies and regulatory approaches

On 1 and 2 December, International Coalition of Medicines Regulatory Authorities (ICMRA) held a high-level meeting to discuss regulatory challenges, including those faced during the ongoing COVID-19 pandemic. Participants from the 24 members and 13 associated members and experts from the World Health Organization and the European Commission also discussed the path towards regulatory alignment on the global response to the Omicron variant. 

The meeting was hosted by the Brazilian National Health Surveillance Agency (ANVISA) and co-chaired by Antonio Barra Torres, Director of ANVISA, and Emer Cooke, Chair of ICMRA and EMA’s Executive Director. A meeting report summarising the outcomes of the discussions is available below:

File

ICMRA Summit and Plenary 2021 Meeting Report.pdf